Superoxide anions, free-radical scavengers, and nitrergic neurotransmission

被引:33
作者
Gibson, A
Lilley, E
机构
[1] Pharmacology Group, Biomedical Sciences Division, Kings's College London
来源
GENERAL PHARMACOLOGY | 1997年 / 28卷 / 04期
关键词
antioxidants; free radical scavengers; nitric oxide; nitrergic nerves; superoxide anions;
D O I
10.1016/S0306-3623(96)00281-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. There is now strong evidence that the L-arginine/nitric oxide (NO) pathway generates the transmitter released from certain nonadrenergic, noncholinergic nerves that mediate smooth-muscle relaxation in the respiratory, gastrointestinal, and urogenital tracts. In particular, nitric oxide synthase (NOS) has been detected in these nitrergic nerves, and nerve-induced relaxation can be prevented by NOS inhibitors. Thus, free-radical NO has been considered the putative transmitter candidate. 2. Despite such evidence, a number of superoxide anion-generating compounds and direct NO scavengers have been found to abolish relaxations to exogenous NO, but to have very little effect on relaxations in response to nitrergic field stimulation. A number of hypotheses have been put forward to explain this paradox: first, that the NO generated within the nerve is attached to a carrier molecule (such as a thiol) to form an adduct, that is released into the junctional gap and that is resistant to superoxide anions and other scavengers; second, that over short distances (up to 200 mu m) the rapid diffusion characteristics of NO render it resistant to inhibition by scavengers; third, that NO is indeed released as a free radical, but that it is protected from radical scavengers by other substances present in the junctional region. 3. Recent experimental evidence supports the third explanation, because nitrergic relaxations, normally resistant to inhibition by superoxide anions, become sensitive following inactivation of copper/zinc superoxide dismutase (Cu/Zn SOD); the inhibition can he reversed by adding exagenous Cu/Zn SOD (or ascorbate). In addition, the ability of two NO-scavenger compounds, hydroquinone and carboxy-PTIO, to inhibit relaxations to exogenous NO is prevented by certain physiological antioxidants (ascorbate and reduced glutathione in the case of hydroquinone, and ascorbate and alpha-tocopherol in the case of carboxy-PTIO). 4. Thus, it is possible that the presence of integrated antioxidant mechanisms within the tissue protects neuronally-released NO from attack by scavenging molecules; exogenous NO would be vulnerable before reaching the protection of the tissue, thus explaining the paradoxical effects mentioned. Organ antioxidant status may therefore be very important in preserving the potency of nitrergic transmission and in preventing NO from reacting with other compounds to produce cytotoxic metabolites (eg., with superoxide anions to form peroxynitrite). (C) 1997 Elsevier Science Inc.
引用
收藏
页码:489 / 493
页数:5
相关论文
共 37 条
[1]   ANTAGONISTIC ACTION OF IMIDAZOLINEOXYL N-OXIDES AGAINST ENDOTHELIUM-DERIVED RELAXING FACTOR .NO THROUGH A RADICAL REACTION [J].
AKAIKE, T ;
YOSHIDA, M ;
MIYAMOTO, Y ;
SATO, K ;
KOHNO, M ;
SASAMOTO, K ;
MIYAZAKI, K ;
UEDA, S ;
MAEDA, H .
BIOCHEMISTRY, 1993, 32 (03) :827-832
[2]   INFLUENCE OF S-NITROSOTHIOLS AND NITRATE TOLERANCE IN THE RAT GASTRIC FUNDUS [J].
BARBIER, AJM ;
LEFEBVRE, RA .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 111 (04) :1280-1286
[3]   EFFECT OF LY-83583 ON RELAXATION INDUCED BY NONADRENERGIC NONCHOLINERGIC NERVE-STIMULATION AND EXOGENOUS NITRIC-OXIDE IN THE RAT GASTRIC FUNDUS [J].
BARBIER, AJM ;
LEFEBVRE, RA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 219 (02) :331-334
[4]   NADPH-CYTOCHROME REDUCTASE CATALYZED REDOX CYCLING OF 1,4-BENZOQUINONE - HAMPERED AT PHYSIOLOGICAL CONDITIONS, INITIATED AT INCREASED PH VALUES [J].
BOERSMA, MG ;
BALVERS, WG ;
BOEREN, S ;
VERVOORT, J ;
RIETJENS, IMCM .
BIOCHEMICAL PHARMACOLOGY, 1994, 47 (11) :1949-1955
[5]  
BOLANOS JP, 1995, J NEUROCHEM, V64, P1965
[6]   NITRIC-OXIDE, A NOVEL NEURONAL MESSENGER [J].
BREDT, DS ;
SNYDER, SH .
NEURON, 1992, 8 (01) :3-11
[7]   Inhibition of nitrergic relaxations by a selective inhibitor of the soluble guanylate cyclase [J].
Cellek, S ;
Kasakov, L ;
Moncada, S .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (01) :137-140
[8]  
DELUCA A, 1990, BRIT J PHARMACOL, V101, P437
[9]  
GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184
[10]   GLUTAMATE, NITRIC-OXIDE AND CELL CELL SIGNALING IN THE NERVOUS-SYSTEM [J].
GARTHWAITE, J .
TRENDS IN NEUROSCIENCES, 1991, 14 (02) :60-67